Download Files:
LN5P45
SKU
HY-149482-Get quote
Category Reference compound
Tags Cancer, Cathepsin, Metabolic Enzyme/Protease
Products Details
Product Description
– LN5P45 is an OTUB2 inhibitor (IC50: 2.3 μM). LN5P45 induces monoubiquitination of OTUB2 on lysine 31. LN5P45 can be used for research of tumor progression and metastasis[1].
Web ID
– HY-149482
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C13H15ClN2O2
References
– [1]Gan J, et al. Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2. ACS Chem Biol. 2023 Aug 29.
Molecular Weight
– 266.72
SMILES
– CC1=CC=CC([C@H]2C[C@@H]2C(NNC(CCl)=O)=O)=C1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Cathepsin
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.